#SLNO

Neurocrine Biosciences Posts 39% Revenue Growth Amid KINECT-PRO Clinical Wins

Neurocrine Biosciences balances robust 39% revenue growth and positive clinical data for INGREZZA against a tightened balance sheet following its $2.9 billion…